期刊
MICROCHIMICA ACTA
卷 174, 期 3-4, 页码 353-360出版社
SPRINGER WIEN
DOI: 10.1007/s00604-011-0633-0
关键词
Fluorescence; Levofloxacin; Moxifloxacin; Terbium; Colloidal silver nanoparticles
资金
- Kyungpook National University
- Ministry of Education, Science and Technology [2009-0093819]
We report on a fluorometric method for the determination of the fluoroquinolones levofloxacin (LEV) and moxifloxacin (MOXI). It is based on the Tb(III)-sensitized luminescence that is plasmonically enhanced by silver nanoparticles (Ag NPs). The emission of the Tb(III) complexes has maximum at 545 nm after excitation at 284 nm and is strongly enhanced in the presence of the colloidal Ag NPs. Under optimum experimental conditions, luminescence intensity increases linearly with the concentration in the range from 4.16 x 10(-17)-3.59 x 10(-15) M of LEV, and from 4.98 x 10(-17)-2.49 x 10(-15) M for MOXI with correlation coefficients of 0.9996 and 0.9996, respectively. The limits of detection are 7.19 x 10(-18) M and 8.47 x 10(-18) M, respectively, and the relative standard deviations are 1.3 and 1.5% for 5 replicate measurements at 6.08 x 10(-14) M of LEV and 5.48 x 10(-14) M of MOXI. The method was successfully applied to the determination of LEV and MOXI in pharmaceutical samples, in urine and in serum.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据